+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carcinoma Drug"

Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Head & Neck Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Head & Neck Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Advanced Urotheilal carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Urotheilal carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Thymic Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Thymic Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adenoid Cystic Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Nasopharyngeal Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
Loading Indicator

Carcinoma drugs are a type of oncology drug used to treat cancer. They are designed to target and destroy cancer cells while minimizing damage to healthy cells. Carcinoma drugs can be administered orally, intravenously, or topically, depending on the type of cancer being treated. Common types of carcinoma drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of carcinoma drug that uses drugs to kill cancer cells. Targeted therapy is a type of drug that targets specific molecules in cancer cells, such as proteins or genes, to stop the growth and spread of cancer. Immunotherapy is a type of drug that helps the body’s immune system fight cancer. Hormone therapy is a type of drug that blocks hormones that can cause cancer cells to grow. The carcinoma drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AstraZeneca, Eli Lilly, GlaxoSmithKline, and Sanofi. Show Less Read more